Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

KVUE.US Logo

KVUE.US - Current Price

$17.12

Company Information

Company Name
Kenvue Inc.
Sector
Consumer Defensive
Industry
Household & Personal Products
Exchange
NYSE
ISIN: US49177J1025
CIK: 0001944048
CUSIP: 49177J102
Currency: USD
Full Time Employees: 22,000
Phone: 908-874-1200
Fiscal Year End: December
IPO Date: May 04, 2023
Description:

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Address:

1 Kenvue Way, Summit, NJ, United States, 07901

Directors & Officers

Name Title Year Born
Mr. Kirk L. Perry CEO & Director 1967
Ms. Meredith Stevens Chief Operations Officer 1963
Mr. Carlton Lawson Group President of EMEA & Latin America 1969
Mr. Amit Banati Chief Financial Officer 1969
Ms. Heather R. Howlett Chief Accounting Officer 1978
Mr. Michael Wondrasch Chief Technology & Data Officer 1969
Dr. Caroline Tillett Ph.D. Chief Scientific Officer 1972
Ms. Sofya Tsinis Head of Investor Relations NA
Mr. Matthew Orlando General Counsel 1977
Mr. Jonathan Halvorson Chief Digital & Marketing Officer NA

Shares Statistics

Shares Outstanding: 1.92B
Shares Float: 1.91B
% Insiders: 3.70%
% Institutions: 9,892.70%
Short % Float: 4.33%

Valuation Metrics

Enterprise Value: $40.54B
Trailing P/E: 22.67
Forward P/E: 15.41

Financial Highlights

Market Cap: $32.57B
EBITDA: $3.54B
P/E Ratio: $22.67
PEG Ratio: $0.87
Book Value: $5.55
Dividend/Share: $0.82
Dividend Yield: 4.89%
Earnings/Share: $0.75
Profit Margin: 9.55%
Operating Margin: 19.29%
ROA (TTM): 6.86%
ROE (TTM): 13.47%
Revenue (TTM): $15.01B
Revenue/Share (TTM): $7.83
Earnings Growth (YOY): 3.80%
Revenue Growth (YOY): -3.50%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 N/A 0.23 N/A N/A
Sep 30, 2025 0.28 0.26 N/A 769.23%
Jun 30, 2025 0.29 0.28 N/A 357.14%
Mar 31, 2025 0.24 0.23 N/A 434.78%
Dec 31, 2024 0.15 0.20 N/A -2,500.00%
Sep 30, 2024 0.28 0.27 N/A 370.37%
Jun 30, 2024 0.32 0.28 N/A 1,428.57%
Mar 31, 2024 0.28 0.25 N/A 1,200.00%
Dec 31, 2023 0.31 0.28 N/A 1,071.43%
Sep 30, 2023 0.31 0.31 N/A 0.00%
Jun 30, 2023 0.32 0.30 N/A 666.67%
Mar 31, 2023 0.19 0.32 N/A -4,062.50%
Dec 31, 2022 0.91 0.00 N/A N/A
Jun 30, 2022 0.22 0.00 N/A N/A

Balance Sheet (Yearly)

Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $1.07B $N/A $25.60B $15.93B $9.67B
2023-12-31 $1.38B $N/A $27.85B $16.64B $11.21B
2022-12-31 $1.23B $N/A $27.32B $7.35B $19.97B
2021-12-31 $740.00M $N/A $27.93B $7.53B $20.40B
2020-12-31 $618.00M $N/A $29.18B $10.82B $18.36B
2019-12-31 $N/A $N/A $N/A $N/A $N/A

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 29, 2025 N/A N/A N/A N/A N/A N/A
Sep 25, 2025 N/A N/A N/A N/A N/A N/A
Sep 23, 2025 N/A N/A N/A N/A N/A N/A
Aug 28, 2025 N/A N/A N/A N/A N/A N/A
Aug 26, 2025 N/A N/A N/A N/A N/A N/A
Aug 04, 2025 N/A N/A N/A N/A N/A N/A
Jul 01, 2025 N/A N/A N/A N/A N/A N/A
Jun 16, 2025 N/A N/A N/A N/A N/A N/A
Nov 18, 2024 N/A N/A N/A N/A N/A N/A
Aug 06, 2024 N/A N/A N/A N/A N/A N/A
Aug 01, 2024 N/A N/A N/A N/A N/A N/A
Sep 20, 2023 N/A N/A N/A N/A N/A N/A
Sep 08, 2023 N/A N/A N/A N/A N/A N/A
Aug 30, 2023 N/A N/A N/A N/A N/A N/A
Aug 10, 2023 N/A N/A N/A N/A N/A N/A
Aug 03, 2023 N/A N/A N/A N/A N/A N/A
Aug 02, 2023 N/A N/A N/A N/A N/A N/A
May 11, 2023 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist